Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy
Hongye Zou(University of California, Davis), Hong-Wu Chen(University of California, Davis)
Cited by 11
Related Papers
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
|Acta Pharmaceutica Sinica B|2023|14
Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner
|Frontiers in Pharmacology|2023|9